A detailed history of Glenmede Trust CO Na transactions in Moderna, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 3,463 shares of MRNA stock, worth $227,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,463
Previous 2,992 15.74%
Holding current value
$227,692
Previous $318,000 29.25%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $47,669 - $78,473
471 Added 15.74%
3,463 $411,000
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $255,427 - $345,396
2,992 New
2,992 $318,000
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $53,857 - $78,216
-397 Reduced 11.09%
3,184 $488,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $170,940 - $303,297
1,444 Added 67.57%
3,581 $643,000
Q3 2022

Nov 16, 2022

BUY
$118.07 - $194.18 $21,370 - $35,146
181 Added 9.25%
2,137 $252,000
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $3,162 - $4,767
27 Added 1.4%
1,956 $278,000
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $95,097 - $176,757
-752 Reduced 28.05%
1,929 $331,000
Q4 2021

Feb 15, 2022

SELL
$225.82 - $368.51 $72,939 - $119,028
-323 Reduced 10.75%
2,681 $680,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $269,830 - $589,115
1,216 Added 68.01%
3,004 $1.16 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $266,315 - $481,709
-2,050 Reduced 53.41%
1,788 $419,000
Q1 2021

May 18, 2021

BUY
$109.18 - $185.98 $419,032 - $713,791
3,838 New
3,838 $501,000
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $107,879 - $278,740
-1,641 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$54.34 - $94.85 $5,216 - $9,105
-96 Reduced 5.53%
1,641 $115,000
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $126,483 - $341,040
-4,263 Reduced 71.05%
1,737 $111,000
Q3 2019

Nov 14, 2019

BUY
$12.26 - $18.07 $36,780 - $54,210
3,000 Added 100.0%
6,000 $95,000
Q1 2019

May 14, 2019

BUY
$14.45 - $23.7 $43,350 - $71,100
3,000 New
3,000 $61,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.